Thoughtforms Life Cancer: mitochondria and metabolism - a discussion with Thomas Seyfried and his group
6 snips
Mar 17, 2026 
Thomas Seyfried, a mitochondrial metabolic cancer researcher; Derek Lee, who defined mitochondrial substrate-level phosphorylation; and Tomás Duraj, a clinician-scientist translating metabolic oncology into practice. They explore the mitochondrial theory of cancer, ketogenic and glutamine-targeting metabolic therapies, bioelectric and ion-channel links to metabolism, and translational challenges from mice to humans.
AI Snips
Chapters
Transcript
Episode notes
Cancer As A Mitochondrial Metabolic Disease
- Cancer is primarily a mitochondrial metabolic disease rather than a nuclear gene-driven disorder.
- Thomas Seyfried argues tumors show widespread mitochondrial structural/function defects and shift from OXPHOS to glucose and glutamine fermentation producing lactate and succinate.
Dual Fermentation Pathways Drive Tumor ATP
- Tumor cells use substrate-level phosphorylation in two fermentative compartments: cytoplasmic glycolysis and mitochondrial glutaminolysis.
- Derek Lee's experiments showed cells grown on glutamine alone produce ATP and release succinate even under hypoxia or cyanide.
Apply Press Pulse Ketogenic Metabolic Therapy
- Use a ketogenic metabolic Press-Pulse strategy: press glucose down with diet/exercise and elevate ketones, then pulse with drugs targeting glutamine.
- Seyfried says blocking both glucose and glutamine deprives metastatic tumor hybrids of fuel and kills them.